$PFE

Albert Bourla

Pfizer

Chairman & CEO • Since 2019 • Health Care

📊 CEO Reputation Score

FY2025 vs FY2024 · Source: SEC EDGAR filings

29/100

Blend of this company's year-over-year free-cash-flow and profit improvement, each ranked as a percentile against every scored company in the three indexes.

Free cash flow: $9.8B → $9.1B (−7.7% YoY) — fiscal 2025 vs fiscal 2024
Profit (net income): $8.0B → $7.8B (−3.2% YoY) — fiscal 2025 vs fiscal 2024

How this score works · S&P 500 reputation leaderboard

Overview

Albert Bourla is the chairman & ceo of Pfizer since 2019. Pfizer is a Health Care company headquartered in New York City, New York, founded in 1849, and one of the 500 companies in the S&P 500 — every one of which is profiled on this site.

Leadership

Albert holds the chief executive role at Pfizer with the title Chairman & CEO — in post since 2019. This page is the concise leadership record for Pfizer in the S&P 500 CEO index; the site's fully researched long-form profiles (career timelines, education, achievements, setbacks, philosophy and sourced quotes) currently cover the index's ten largest companies, and this entry will be expanded in the same format.

At a Glance

Sector: Health Care
Ticker: $PFE
Headquarters: New York City, New York
Founded: 1849
CEO since: 2019
Index: S&P 500 (#360 of 500)